Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Thx. I have not received any communication nor read any new PRs. I didn’t know if I was missing something.
Frrol. Where has Leo become more communicative? Last PR was almost 45 days ago. No blogs either. I know you said he emailed you, but was there other emails I missed?
Tia
Great week! Got a whole bunch at.33. Looking for news next week. If none: I say a deal is imminent.
Only 40 min to buy back JT
Bid creeping up here. Let’s go all you swing traders. Monday news puts this in the mid dollar range
Something will be announced next week. Not quite sure what though. IMO. Long weekend of golf to help me pass the time
Be wary wary careful Leo. There is a wabbit lurking.
Ipix will close its first multi partner deal soon! IMO.
I can’t wait to get back to the days of moving up quarters and more in a day. I mean.....as I’ve posted with facts: we were at 4.40 in a much riskier position. We now have proof...to back up reason for pay
SUPER BULL HERE: If I was one investing in a partnership with IPIX and I was a publicly traded company. I would 100% want them to drop news of BTD after I announce the new partnership to the world. This way my shareholders get very excited after digesting the news of the partnership with IPIX.
Just saying. Things will be done accordingly. It is the way of the BILLION DOLLAR BP's.
It is....haha. 4 inches of rain and another 7K shares added
Exactly. Blows my mind. The silence has some really uptight it appears.
JAZZ went down to .50 from mid teens at one point. So .30 from $4 is nothing ;). Oh and then JAZZ sold for what? Anything can happen here and we are unknown to the real market still.
Or he legit can’t talk about it. Multiple license agreement for B-OM will be finalized soon. Then the man can speak freely again....unless..................more deals are being worked after for P
Bullshit. There are delays - all the time in biotech. Watch the results be out of this world and I will remind you daily when that happens. 50% pasi 75 could be sold that day for over 5 billion. IMO.
It’s accurate. Look at page 68/69 of Last K. All the same as yesterday’s.
If you go back to 2013 K you will see Menon had 49 million
All accurate.
We are going to see the DATA LOCK PR in the next few trading days is my guess. And then we will see an increase in SP in anticipation of top line. All this BS will be forgotten when we post +30% pasi 75.
In between the lock and topline I bet wee see BTD as well. .36 is gonna look soooooo good after the above happens. IMO.
I see 4%
Link? Again you are spreading lies and can be held accountable from this site. I have one where the company is in litigation with a multiple alias poster from this site. Just FYI.
Where do you see that? Please post
Vlady. Educated guess. MGMT is 100% behind "business development" right now. That means deals and multiple deals. This is a small company and many forget that.....but they are super small and for what they have accomplished it may seem like a full staff and huge biotech but this is super small. They have dedicated resources allocated to each phase and pipeline and the main focus has been entertaining CDA's and weighing options.
The option of hiding data because of failure is impossible. Literally a zero percent chance on that. Leo has openly admitted that the trial is still BLIND. They have no data as of last week. They will get the data lock notification and then notify us. From there they will dice the data and present it to shareholders. From the Phase 2a and from pre-clinical data I think we have an exceptional chance for STELLAR data and that has not changed with this delay.
I just feel that negotiations and first license deal is the priority now. Money possibly owed to the CRO for P trial may have went to other areas - manufacturing etc...for B prior to P data. Leo said he used some low financing for a lump sum that was needed "NOW" and thats what they had to do and I hope to see in the near future that decision pays off in multiples of a 100.
This is a toxic board and leads imagination furthest from the truth. MGMT will let their actions speak when the time is right. The quiet is welcoming and the share price is taking a hit but what is to come will hopefully allow us to never look back.
JMO
Daubs.
No. The company is working towards their goals and the goals of us shareholders. I would like to see an inked deal for ATLEAST B-OM in the near future. That is what ipix is doing right now. The long in between trials and delays are part of every biotech story.....it is no different here. The difference is people like you who post what you post. Just saying....I don’t need to read day xxx since trial over every day. It does not help anyone. Shareholders understand the results are delayed.
Agree. This is the hands down worst board I read. Pointless and relentless drivel. On the other hand....that gives me extreme optimism.
Leo said in my words: An update is coming. It will follow suit to previous trials: a). Data lock pr. B) topline data pr to follow.
B deal and BTD will also be in upcoming PRs as the company is working on it.
Why the .25 give away. Company needed cash fast for future trials/drug manufacturing and current trial obligations. There was no time to slow roll weeks upon months of 50-100k of shares.
Prurisol data is coming - delay was due to pre set allocations of resources. Things needed to get done prior to other things and we will all find out why shortly.
Frrol posted it on Saturday morning I think.
Could it be.....there was a substantial deal sitting at 3rd base with 1 out over a year ago. And a short pop fly to left with a throw out at home happened?
That could actually explain a ton.
Ask Leo if they believed that had a significant deal last year that fell thru.
That would explain the scramble in my eyes. But the good news is...if this is true, it was only one player and there is a line of next players. But time is the downfall. IMO.
Thank you. I’m jealous you got a response and I have not. :(
Revisiting the Ipix website is a good place to clear ones head. I suggest many go there to get a grip of reality.
I have emailed that question. No response. I’m feeling they are on lock down - hush hush right now. I have not gotten a response in a very long time. Unusual.
I also emailed asking if they had the FDA meeting. No response
Thanks for the info. Good info and really opens the eyes on just how much data is being collected for this trial. From my understanding - and I really do not know, but I thought the CRO was in charge of the trial sites and data collection. I thought the company was in charge of reading and displaying the data.
Normally in the past we always received a DATA LOCK PR email from Leo.
We did not receive that on this round or maybe IPIX has not gotten the data lock confirmation - meaning the CRO is still collecting data.
I thought that once the CRO had all site data and sign-off's - they would notify IPIX and then IPIX notified shareholders DATA LOCK - meaning no more changes to data retrieval can be made.
I saw an email 3 weeks ago that they were still working with the CRO. I believe KarinCA just posted last week that Leo said he was still working with the CRO as well or waiting for data.
So IMO - -- AGAIN IMO --- IPIX is waiting for the data. Once they get the data they will dice it up and present it to us. Maybe the CRO does that but I was under the impression that the company analyzes the data and it takes several weeks.
If anyone has more info on this process - please share.
We still may get a data lock PR in the future and then for sure we will see data in Q3. I don't really care when we see the data, but I do hope the data is better than OTEZLA -
Over the month I’ve seen correspondence from Leo to others.
Most go like: have you seen the data or do you have data?
Leo: we are actively working with the CRO, and fully engaged in “business development”
So to me. I take it as....the CRO is working on it. There is a delay....is there not? WHO is in charge of the trial and data collection? The CRO.
That’s where I get my opinion
How can you not be BULLISH if you do your own DD? Shareprice? Okay, yeah --- obviously one cannot be BULLISH on share price. Trial results - I think you can be BULLISH all day. We have not failed. All the DOOMGLOOM posters try and twist data and make it look negative, but overall...lets just start with SAFETY. Read Fierce Biotech news. Everyday you read how safety just kills a development drug. Every IPIX drug is extremely safe. B-ABSSSI had some issues but Dr. M and IPIX lowered the dose and it proved to be comparative with a 7 day dose of Dapto.
You calling Prurisol not a drug, come on man. Then what is going on? Why have there been 3 trials for Prurisol all with the FDA being involved and patients writing surveys on how great their skin feels after taking P? What is that then? Please explain what P is if it's not a drug?
I'm here to listen.
I am bullish on IPIX and bought 4700 more shares last week and will buy more in July if P data is further delayed. Based on pre-clinical and phase 2a data, I believe we have a huge winner and thanks for the CRO having issues with collecting and posting the data in a timely fashion, I am getting discounted shares.
For me - I am good and comfortable investing more because as I've seen in the past with BioTech - lull's bring major opportunity for wealth if you find the right company and right drugs.
That is an unusual string of occurrences. Just like Menon taking a 50% pay cut. Everyone has the power to decide for themselves. We will find out more info in the next Q
Don’t forget. This is pre-revenue biotech. Ipix sells shares for cash to keep moving forward.
My recent post explained they diluted 38 million shares since Dec 2014 but in that time has completed 6 mid stage human trials. 5 were successful. 1 is hanging in the wind...any day data can be released. Will ipix be batting 1000 ???
I’m betting yes. And I’m betting this trial shows we are better than Otezla. A drug that is marked as a blockbuster with horrid side effects
Toughest part of investing is right here and right now for most. There is nothing negative - just delays and uncertainties and a very unusual string of occurrences.
Three options
-buy more
-hold
-sell
It’s not tough. Everyone has the power to decide.
Quiet periods can make one a lot of money. Do your own DD
Great Post. But according to Bun this company is trash and Has no drugs
One day. They will arrive
Newbies read here-facts.
Dec 31st 2014 - Share price - $4.40
Cash on hand - 9.4 million
Total OS - 117 Million (ish)
PROGRESS
1) Kevetrin - In Progress Phase 1 - Enrolling in the 10th cohort
2) Prurisol - Successful Phase 1 Completed - Comparing bio-availability b/w P and Ziagen
3) B-Absssi - Successful Phase 2b Completed - Topline data Oct 23rd - full data in 2015 to be announced
4) B-OM - IND filed in Sept 2014 and granted by FDA in Oct 2014
**2 Successful Human Trials to date**
https://www.bamsec.com/filing/147793215001033?cik=1355250
Posted in Feb2015 for Q ending Dec 31st 2014
March 31st 2018 - Share price - .52
Cash on hand - 3.3 million
Total OS - 155 Million
PROGRESS
1) Kevetrin - Phase 1 Successful (Solid Tumors)
2) Kevetrin - Phase 2 Successful (Ovarian)
3) Prurisol - Phase 2a Successful (Mild - Moderate Psoriasis)
4) Prurisol - Phase 2b Completed (Moderate - Severe Psoriasis) DATA ANY DAY
5) B-OM - Phase 2 Successful (Oral Mucositis - PREVENTION) Leader in an untapped market
6) B-UP/UC - Phase 2 PoC Successful
**5 Additional late stage Human trials SUCCESSFUL - Awaiting data on a Phase 2b for Prurisol**
So to summarize - in 3.5 years IPIX was able to complete 5 SUCCESSFUL human trials and awaiting on data for a phase 2b.
The share count increased by about 38 Million shares.
I'd say that is pretty flipping good in this arena. JMO
A partnership will set this company free and the share price will go to all time highs and no one will ever remember this blimp back to .40. IMO The market does not know IPIX and when it does and we can have institutional parties invest 10's of millions if not 100's of millions into our company this will stabilize and re-evaluate.
Here is the BUSINESS DEV portion of the last Q:
Quote:
Business Development Activities
The Company is engaged in discussions and negotiations regarding the out-licensing of its mid-stage, first-in-class clinical assets to global and/or specialty pharmaceutical companies who have expressed an interest in one or more assets in our pipeline. Successfully securing partnerships would afford the Company access to immediate and potentially recurring sources of non-dilutive capital, including upfront fees, milestone-based payments and tiered royalties.
Recently, we released results from our completed Phase 2 Brilacidin study on Oral Mucositis. The results have attracted inquiries, additional confidential disclosure agreements, and discussions with pharmaceutical companies
https://www.bamsec.com/filing/147793218002302?cik=1355250
I’d like those examples too
When we close the deal it will happen. I’m just hoping the deal is for all of B and in the billions by the time all milestones are hit to approval.
So so so quiet.
Common Sense: If Leo has results, we would know. People saying or thinking results are bad and that is the delay are not intelligent. I’m not saying you are saying that.
PP had good scenarios, I’d lean towards CRO and sites including all the surveys. Based on pre clinical and some old info I read today regarding Prurisol pre clinical data, extremely promising and industry shaking results are not out of the question from our oral drug. I was reading the mice treated had zero reoccurrence of the disease.
I wonder if our competitor had similar results in mice
Ha. Blip. Sorry. Damn auto correct.
I do think these past years and this year especially will be a forgotten blip by most but for many of us we will never forget because we will reap the benefits of the 38 million in dilution that brought us here including all the bs short articles —- we will never forget because that is how I gained 10x my initial holding goal and it’s not over yet. Hoping to get to 15x my goal.
So 15x my goal in holdings and ipix only diluted by 25% in that time. If I’m right about Ipix....these past 3-4 years are going to be a phenomenal gift.
Here are a few facts to keep in mind regarding progress:
Dec 31st 2014 - Share price - $4.40
Cash on hand - 9.4 million
Total OS - 117 Million (ish)
PROGRESS
1) Kevetrin - In Progress Phase 1 - Enrolling in the 10th cohort
2) Prurisol - Successful Phase 1 Completed - Comparing bio-availability b/w P and Ziagen
3) B-Absssi - Successful Phase 2b Completed - Topline data Oct 23rd - full data in 2015 to be announced
4) B-OM - IND filed in Sept 2014 and granted by FDA in Oct 2014
**2 Successful Human Trials to date**
https://www.bamsec.com/filing/147793215001033?cik=1355250
Posted in Feb2015 for Q ending Dec 31st 2014
March 31st 2018 - Share price - .52
Cash on hand - 3.3 million
Total OS - 155 Million
PROGRESS
1) Kevetrin - Phase 1 Successful (Solid Tumors)
2) Kevetrin - Phase 2 Successful (Ovarian)
3) Prurisol - Phase 2a Successful (Mild - Moderate Psoriasis)
4) Prurisol - Phase 2b Completed (Moderate - Severe Psoriasis) DATA ANY DAY
5) B-OM - Phase 2 Successful (Oral Mucositis - PREVENTION) Leader in an untapped market
6) B-UP/UC - Phase 2 PoC Successful
**5 Additional late stage Human trials SUCCESSFUL - Awaiting data on a Phase 2b for Prurisol**
So to summarize - in 3.5 years IPIX was able to complete 5 SUCCESSFUL human trials and awaiting on data for a phase 2b.
The share count increased by about 38 Million shares.
I'd say that is pretty flipping good in this arena. JMO
A partnership will set this company free and the share price will go to all time highs and no one will ever remember this blimp back to .40. IMO The market does not know IPIX and when it does and we can have institutional parties invest 10's of millions if not 100's of millions into our company this will stabilize and re-evaluate.
Here is the BUSINESS DEV portion of the last Q:
Business Development Activities
The Company is engaged in discussions and negotiations regarding the out-licensing of its mid-stage, first-in-class clinical assets to global and/or specialty pharmaceutical companies who have expressed an interest in one or more assets in our pipeline. Successfully securing partnerships would afford the Company access to immediate and potentially recurring sources of non-dilutive capital, including upfront fees, milestone-based payments and tiered royalties.
Recently, we released results from our completed Phase 2 Brilacidin study on Oral Mucositis. The results have attracted inquiries, additional confidential disclosure agreements, and discussions with pharmaceutical companies.